| |
| |
|
| Insider
Information: |
Alimi Hojabr |
| Relationship: |
CEO and Chief Science ... |
| City: |
Petaluma |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,156,050 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$736,170 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,156,050 |
|
|
| Total
Value |
$736,170 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sonoma Pharmaceuticals Inc |
SNOA |
Chief Executive Office... |
2012-12-10 |
1,031,050 |
|
0 |
Premium* |
|
|
Pulmatrix Inc |
PULM |
CEO and Chief Science ... |
2014-05-11 |
125,000 |
2014-05-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PULM |
Pulmatrix Inc |
CEO and Chief Science Officer |
• • – |
2014-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
125,000 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2012-12-10 |
4 |
B |
$0.64 |
$3,507 |
D/D |
5,500 |
1,031,050 |
2.73 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2012-12-07 |
4 |
B |
$0.65 |
$3,438 |
D/D |
5,300 |
1,031,050 |
2.73 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2012-12-06 |
4 |
B |
$0.63 |
$5,703 |
D/D |
9,000 |
1,020,250 |
2.81 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2010-03-10 |
4 |
S |
$3.16 |
$47,343 |
D/D |
(15,000) |
1,011,250 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2010-03-09 |
4 |
OE |
$1.10 |
$16,500 |
D/D |
15,000 |
1,026,250 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2009-08-10 |
4 |
S |
$1.97 |
$658,277 |
D/D |
(315,000) |
1,011,250 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2009-08-10 |
4 |
OE |
$0.15 |
$48,300 |
D/D |
315,000 |
1,326,250 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2009-03-06 |
4 |
S |
$1.05 |
$13,853 |
D/D |
(13,200) |
1,011,250 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2009-03-05 |
4 |
S |
$1.14 |
$8,923 |
D/D |
(7,800) |
1,024,450 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2009-03-04 |
4 |
S |
$1.16 |
$20,568 |
D/D |
(17,800) |
1,032,250 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2009-03-03 |
4 |
S |
$1.23 |
$7,648 |
D/D |
(6,200) |
1,050,050 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2008-03-07 |
4/A |
S |
$5.36 |
$80,400 |
D/D |
(15,000) |
981,250 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2008-03-07 |
4 |
D |
$5.36 |
$80,400 |
D/D |
(15,000) |
981,250 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
CEO, President |
• • – |
2007-11-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,500 |
996,250 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
President & CEOOfficer |
• • – |
2007-01-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,008,750 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
